Share Email Print
cover

Proceedings Paper

Using alpha-interferon as an adjunctive therapy to reduce the dose of energy required with photodynamic therapy in treating human bladder tumors: cell culture results
Author(s): David Hall; Unyime O. Nseyo; Dale Riggs; Barbara Jackson; Donald L. Lamm
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Carcinoma in situ (CIS) of the bladder has long been known as an aggressive killer. Because of the high degree of progression to muscle invasion and the high rate of occult early metastasis, early radical cystectomy had been the preferred treatment, a highly morbid procedure. Even now, with routine use of continent diversions or oithotopic bladder replacements, most patients would agree that there is still a great deal of morbidity associated with this treatment.

Paper Details

Date Published: 31 January 2001
PDF: 4 pages
Proc. SPIE 4156, Clinical Lasers and Diagnostics, (31 January 2001); doi: 10.1117/12.413705
Show Author Affiliations
David Hall, West Virginia Univ. (United States)
Unyime O. Nseyo, Medical College of Virginia/Virginia Commonwealth Univ. (United States)
Dale Riggs, West Virginia Univ. (United States)
Barbara Jackson, West Virginia Univ. (United States)
Donald L. Lamm, West Virginia Univ. (United States)


Published in SPIE Proceedings Vol. 4156:
Clinical Lasers and Diagnostics
Patrick Brouwer, Editor(s)

© SPIE. Terms of Use
Back to Top